SSG
MBOT icon

Summit Securities Group’s Microbot Medical MBOT Stock Holding History

Summit Securities Group’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-2
Closed -$6K – 503
2013
Q2 		$6K Buy
+2
New +$5.64K ﹤0.01% 369

Other funds holding MBOT

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Summit Securities Group's MBOT Position: Q3 2013 in Review

Summit Securities Group sold out of Microbot Medical (MBOT) in Q3 2013, closing a stake of 2 shares — an estimated $6K sold.

Summit Securities Group first reported a position in MBOT in Q2 2013 and held it in 1 quarter. The position peaked at $6K in Q2 2013. 26 funds tracked by Wall St. Rank hold MBOT as of Q3 2013.

  • Summit Securities Group reported no remaining Microbot Medical position as of Q3 2013 after selling out during the quarter.
  • Summit Securities Group sold 2 Microbot Medical shares in Q3 2013, an estimated $6K.
  • Summit Securities Group first reported a position in Microbot Medical in Q2 2013 and held it in 1 quarter.
  • Summit Securities Group's Microbot Medical position peaked at $6K in Q2 2013.
  • 26 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2013.

Based on Summit Securities Group's 13F filing for Q3 2013, filed 1 Nov 2013.